nLife Therapeutics to launch EUR 20m capital raise
nLife Therapeutics abrirá una ronda de financiación de EUR 20m
Intel ID : 237814
| Synopsis |
|
nLife Therapeutics, a Spanish biotechnology company, plans to begin a capital raise for EUR 20m to launch its new drug for Parkinson's disease, as published by newspaper ABC on 15 June 2016, citing its biology director, Raquel Revilla. The objective is to raise at least EUR 20m, to face the clinical phase of the drug, and to develop, at the same time, other medicines in its drug technology platform. Futhermore, Raquel Revilla said that "it is important to reach an agreement with a pharmaceutical company and with private investors, such as venture capital firms".
(content in spanish)
nLife Therapeutics, empresa española de biotecnología, tiene previsto abrir una ronda de financiación de EUR 20m para lanzar su fármaco contra el Parkinson, según ha informado el diario ABC el 15 de junio de 2016, basándose en declaraciones de Raquel Revilla, directora de biología de nLife Therapeutics. El objetivo de la compañía andaluza es captar como mínimo esa cifra para poder abordar la fase clínica del compuesto para el Parkinson y desarrollar, al mismo tiempo, el resto de medicamentos de su plataforma tecnológica de fármacos. En este sentido, Raquel Revilla señala que "es importante un acuerdo con una farmacéutica y con inversores privados, como sociedades de capital riesgo". |
|
||||
| Intel ID | 237814 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - nLife Therapeutics
(31 Dec 2016) |
Revenue: EUR 1,96m Net Debt: EUR 18,85m |
|
| Date |
 |
|
| Country | |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.99 Other Biotechnology & Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
15.06.01 Colleges & Universities 15 Consumer Products & Services / 15.06 Education & Training Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.